Navigating Regulatory And Privacy Updates In Clinical Trials

In a recent Florence Healthcare webinar, experts, including Dr. PJ Devereux from McMaster University, examined the evolving landscape of clinical trials in Canada, emphasizing the impact of new regulatory changes on participant engagement and retention. The introduction of enhanced privacy legislation aims to bolster data protection and informed consent processes, aligning Canadian standards more closely with global practices. The panel underscored the paramount importance of maintaining participant trust, particularly in light of stringent provincial and federal privacy laws.

Experts proposed that effective communication strategies and flexible trial designs, such as hybrid visits, are essential for minimizing dropout rates and improving overall trial success. Additionally, the discussion highlighted the increasing integration of technology, notably the rise of eConsent since 2019, which facilitates smoother participant interactions. The experts called on Canadian sponsors and sites to proactively adapt to these regulatory shifts by embracing innovative privacy practices and leveraging technological advancements. Explore how the guide for eRegulatory adoption in Canada provides resources to help stakeholders navigate these changes and enhance participant engagement and retention in clinical trials.